Zhongchao (NASDAQ:ZCMD – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday, Wall Street Zen reports.
Separately, Weiss Ratings downgraded Zhongchao from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday, September 25th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has an average rating of “Sell”.
Get Our Latest Stock Report on Zhongchao
Zhongchao Stock Performance
Zhongchao Company Profile
Zhongchao Inc is a China-based healthcare services company that provides medical education and patient-management services. The company focuses on supporting healthcare professionals and patients through digital platforms, educational programs and related healthcare resources.
Its business activities have included continuing medical education for physicians and other medical professionals, as well as disease-management and patient-support services. Zhongchao has particularly emphasized oncology-related healthcare education and management, helping connect medical information, professional training and patient services.
The company primarily serves the healthcare market in China through online and offline offerings.
See Also
- Five stocks we like better than Zhongchao
- Could Nike’s Brutal Sell-Off Finally Be Running Out of Steam?
- The AI Buildout Needs Power It Cannot Get: 4 Energy Stocks Already Have It
- McDonald’s Is Undergoing a Massive New Growth Strategy. Can It Win Back Consumers?
- MGM Resorts Stock Sinks After Diller Deal Collapse: Overreaction or Warning?
Receive News & Ratings for Zhongchao Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zhongchao and related companies with MarketBeat.com's FREE daily email newsletter.
